Michelle L. Basil, EVP and General Counsel at HAEMONETICS CORP (HAE), sold 34,208 shares at $124.54 ($4.2M) on 2019-10-09, disclosed to the SEC on 2019-10-10.
Open-market sale of $4.2M HAE by EVP and General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $122.34 | 8,883 | $1.1M | 25.8% |
| 2 | $122.34 | 8,883 | $1.1M | 25.8% |
| 3 | $122.50 | 1,100 | $135K | 3.2% |
| 4 | $123.50 | 3,724 | $460K | 10.9% |
| 5 | $124.54 | 5,809 | $723K | 17.2% |
| 6 | $124.54 | 5,809 |
| $723K |
| 17.2% |
| Total | $123.22 avg | 34,208 | $4.2M | 100% |
| Filing → |
| HAE | SELL | 2024-05-17 | $189K | — | Filing → |
| HAE | SELL | 2022-10-26 | $14K | — | Filing → |
| HAE | SELL | 2022-09-21 | $1.8M | — | Filing → |